Your browser doesn't support javascript.
loading
FKBPL: a marker of good prognosis in breast cancer.
Nelson, Laura; McKeen, Hayley D; Marshall, Andrea; Mulrane, Laoighse; Starczynski, Jane; Storr, Sarah J; Lanigan, Fiona; Byrne, Christopher; Arthur, Ken; Hegarty, Shauna; Ali, Ahlam Abdunnabi; Furlong, Fiona; McCarthy, Helen O; Ellis, Ian O; Green, Andrew R; Rakha, Emad; Young, Leonie; Kunkler, Ian; Thomas, Jeremy; Jack, Wilma; Cameron, David; Jirström, Karin; Yakkundi, Anita; McClements, Lana; Martin, Stewart G; Gallagher, William M; Dunn, Janet; Bartlett, John; O'Connor, Darran; Robson, Tracy.
Afiliação
  • Nelson L; School of Pharmacy, Queen's University Belfast, Belfast, United Kingdom.
  • McKeen HD; School of Pharmacy, Queen's University Belfast, Belfast, United Kingdom.
  • Marshall A; Warwick Clinical Trials Unit, University of Warwick, Coventry, United Kingdom.
  • Mulrane L; Conway Institute, University College Dublin, Dublin, Ireland.
  • Starczynski J; Ontario Institute for Cancer Research, Toronto, Canada.
  • Storr SJ; Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, United Kingdom.
  • Lanigan F; Conway Institute, University College Dublin, Dublin, Ireland.
  • Byrne C; Royal College of Surgeons Ireland, Dublin, Ireland.
  • Arthur K; Northern Ireland Molecular Pathology Laboratory, CCRCB, Queens University Belfast, Belfast, United Kingdom.
  • Hegarty S; Department of Pathology, Royal Group of Hospitals, Grosvenor Road, Belfast, United Kingdom.
  • Ali AA; School of Pharmacy, Queen's University Belfast, Belfast, United Kingdom.
  • Furlong F; School of Pharmacy, Queen's University Belfast, Belfast, United Kingdom.
  • McCarthy HO; School of Pharmacy, Queen's University Belfast, Belfast, United Kingdom.
  • Ellis IO; Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, United Kingdom.
  • Green AR; Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, United Kingdom.
  • Rakha E; Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, United Kingdom.
  • Young L; Royal College of Surgeons Ireland, Dublin, Ireland.
  • Kunkler I; Edinburgh Breast Unit, The University of Edinburgh, Edinburgh, United Kingdom.
  • Thomas J; Edinburgh Breast Unit, The University of Edinburgh, Edinburgh, United Kingdom.
  • Jack W; Edinburgh Breast Unit, The University of Edinburgh, Edinburgh, United Kingdom.
  • Cameron D; Edinburgh Breast Unit, The University of Edinburgh, Edinburgh, United Kingdom.
  • Jirström K; Department of Clinical Sciences, Lund University, Sweden.
  • Yakkundi A; School of Pharmacy, Queen's University Belfast, Belfast, United Kingdom.
  • McClements L; School of Pharmacy, Queen's University Belfast, Belfast, United Kingdom.
  • Martin SG; Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, United Kingdom.
  • Gallagher WM; Conway Institute, University College Dublin, Dublin, Ireland.
  • Dunn J; Warwick Clinical Trials Unit, University of Warwick, Coventry, United Kingdom.
  • Bartlett J; Ontario Institute for Cancer Research, Toronto, Canada.
  • O'Connor D; Edinburgh Cancer Research Centre, The University of Edinburgh, Edinburgh, United Kingdom.
  • Robson T; Conway Institute, University College Dublin, Dublin, Ireland.
Oncotarget ; 6(14): 12209-23, 2015 May 20.
Article em En | MEDLINE | ID: mdl-25906750
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Imunofilinas Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Female / Humans Idioma: En Revista: Oncotarget Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Imunofilinas Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Female / Humans Idioma: En Revista: Oncotarget Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Reino Unido